Stapling peptide and application thereof
By modifying the structure of the template peptide SLP-0 and replacing key amino acid residues with lysine, a staple peptide is formed, which solves the hemolytic problem, improves antibacterial activity and structural stability, and is suitable for the preparation of antibacterial drugs.
Patent Information
- Application Number
- CN202510227850.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-05
- Publication Date
- 2025-11-25
AI Technical Summary
The existing template peptide SLP-0 has hemolytic problems during application, which limits its further development and application.
By modifying the structure of SLP-0 and replacing specific amino acid residues with lysine (Lys), staple peptides are formed, such as Ac-LKRVWKRVFKLLKS5YWRS5LKKPVR-NH2, in which amino acid residues 1L, 4V, 5W, 8V, 9F, 11L, 12L, 15Y, 16W, 19L, and 22P are replaced with Lys, forming structurally stable staple peptides.
The hemolytic activity of staple peptides was improved, significantly enhancing their antibacterial activity against Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae, demonstrating their potential as novel antibacterial drugs, while maintaining their resistance to proteolytic degradation.